Go Ad-Free
    My Alerts
    Budget Express 2026

    co-presented by

    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    HomeNews

    Allegra D24

    Jump to

    • Dr Reddy's launches generic Allegra drug in US

      Having won a legal tussle, Dr Reddy's Laboratories on Thursday finally launched its generic Allegra tablets, Fexofenadine HCl, in the US market. DRL will market the over-the-counter product under store brand labels in the US market.

    • See Dr Reddy's FY12 EPS around Rs 80: Anand Rathi

      Number 2 drugmaker Dr Reddy's Laboratories Ltd said a US district court has cleared the sale of its generic version of Sanofi-Aventis' allergy treatment drug Allegra D24. Sriram Rathi, Anand Rathi Financial Services says it is definitely a positive news for Dr Reddy’s.

    • Dr Reddy's says US court clears generic Allegra sale

      Number 2 drugmaker Dr Reddy's Laboratories Ltd said on Monday a US district court has cleared the sale of its generic version of Sanofi-Aventis' allergy treatment drug Allegra D24.

    • Dr Reddy gets US court approval to sell Allegra D24; stk up

      Dr Reddys Laboratories has got US court approval to sell Allegra D24, quoting NewsWire18, reports CNBC-TV18. It touched an intraday high of Rs 1,624 and an intraday low of Rs 1,585.05. At 09:24 hrs the share was quoting at Rs 1,624, up Rs 57.80, or 3.69%.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347